TJP1 and inflammatory bowel disease: Modification or cellular translocation of the tight junction molecules ZO1 and several claudins have indeed been observed in inflammatory bowel disease (IBD) and chronic non-steroidal anti-inflammatory drugs (NSAIDs) use, both characterized by increased intestinal permeability [11,12].